Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of neurodegenerative diseases. The ketogenic diet is a low-carbohydrate and fat-rich diet. Its implementation has a fasting-like effect, which brings the body into a state of ketosis. The ketogenic diet has, for almost 100 years, been used in the therapy of drug-resistant epilepsy, but current studies indicate possible neuroprotective effects. Thus far, only a few studies have evaluated the role of the ketogenic diet in the prevention of Parkinson’s disease (PD) and Alzheimer’s disease (AD). Single studies with human participants have demonstrated a reduction of disease symptoms after application. The application of the ketogenic diet to elderly people, however, raises certain concerns. Persons with neurodegenerative diseases are at risk of malnutrition, while food intake reduction is associated with disease symptoms. In turn, the ketogenic diet leads to a reduced appetite; it is not attractive from an organoleptic point of view, and may be accompanied by side effects of the gastrointestinal system. All this may lead to further lowering of consumed food portions by elderly persons with neurodegenerative diseases and, in consequence, to further reduction in the supply of nutrients provided by the diet. Neither data on the long-term application of the ketogenic diet in patients with neurodegenerative disease or data on its effects on disease symptoms are available. Further research is needed to evaluate the suitability of the ketogenic diet in the therapy of AD- or PD-affected persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
In the citing paper
“Włodarek et al. (106) found that a ketogenic diet, which is high in fat, moderate in protein, and low in carbohydrates, has the potential to reduce neuronal degeneration, and that this specific type of nutritional intervention may provide neuroprotection.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tranfield, D., Denyer, D., & Smart, P. (2003) · British Journal of Management · doi:10.1111/1467-8551.00375 · Cited by 15,386 · cited 1×
“The literature’s analyses on the ketogenic diet in the context of neurodegenerative diseases was based on the principles of a structured literature review, a tool used in developing evidence-based knowledge in a rigorous and relevant way [17].”
MethodBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 1×
“2 g of protein/kg per day, or even more if they are physically active [57].”
BackgroundJasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885 · cited 1×
“In consequence, there is an increased secretion of metabolism nitrogen products, so diuresis in enhanced to maintain a constant dilution of these metabolites in urine [55], while in persons with normal kidney function, it need not exert any negative effects on the body [55].”
BackgroundClinical definition of sarcopenia
Santilli, V (2014) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2014.11.3.177 · Cited by 710 · cited 1×
“Sarcopenia is a problem which affects elderly persons, and its incidence increases with age [56].”
BackgroundThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574 · cited 1×
“Caloric restriction also has anti-inflammatory effects; it can reduce levels of NFkB, the central component of the inflammatory process, and block the synthesis of interleukins (IL1β, IL2, IL4, IL6) and tumor necrosis factors (TNFα) and suppresses the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide syn…”
BackgroundHenderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · cited 2×
“A diet based on medium-chain triglycerides (MCT) was applied as a form of therapy in the 1950s [11], which led to an increase in the concentration of ketone bodies in the blood, even if carbohydrates were present in the diet; thus, this version of KD enables the production of ketone bodies without drastic changes in d…”
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535 · cited 2×
“It was shown that beta-hydroxybutyrate acts in vitro as a neuroprotective agent against the toxicity of MPTP on dopaminergic neurons [7].”
BackgroundManoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · cited 1×
“Imbalance in dopamine metabolism due to oxidative stress has been recognized as a contributor to this disease [21].”
BackgroundEffects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
Research works printed but not linked: 4
- Conklin, 1922, Cause and treatment of epilepsy, Jam. Osteopatic. Assoc., 26, 11
- Guelpa, 1911, A lutte contre l’epilepsie par la desintoxication et par la reduction altimentaire, Rev. Ther. Med. Chir. (Paris), 78, 8
- 2012, Characteristisc of ketogenic diet and its terapeutic properties in central nevous system disorders, Annal Academiae Medicea Silesiensis, 66, 66
- Nazarewicz, 2007, Effects of high fat ketogenic diets, Bromat. Chem. Toksykol., XL, 371
Cited by
Items 101–200 of 315
Pali, D. V., Kim, S., Mantik, K. E. K., Lee, J.-B., So, C., Moon, S., Park, D., Kwak, H., & Kang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157362 · Cited by 29
“In recent years, despite debates, a growing body of research has also suggested that the KD may offer potential therapeutic benefits for various neurodegenerative diseases [110,111].”
Field, R., Field, T., Pourkazemi, F., & Rooney, K. (2022) · Nutrition Research Reviews · doi:10.1017/s0954422422000087 · Cited by 28
“Adoption of a low-carbohydrate diet (LCD) or ketogenic diet (KD) is gaining popularity as a nutritional therapy for many dysfunctions, including those within the nervous system (1 – 3) .”
BackgroundOliveira, T. P. D., Morais, A. L. B., dos Reis, P. L. B., Palotás, A., & Vieira, L. B. (2023) · Metabolites · doi:10.3390/metabo14010025 · Cited by 25
“The KD is a diet based on reducing carbohydrate consumption and increasing lipid intake [70,71].”
BackgroundTanaka, M., & Vécsei, L. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02812-z · Cited by 22
Zhu, Y., Tang, X., Cheng, Z., Dong, Q., & Ruan, G. (2022) · Parkinson s Disease · doi:10.1155/2022/3506213 · Cited by 26
“In view of the feasibility, safety, and efficacy, its application in PD was also investigated [14].”
Saito, E. R., Warren, C. E., Hanegan, C. M., Larsen, J. G., du Randt, J. D., Cannon, M. E., Saito, J. Y., Campbell, R. J., Kemberling, C. M., Miller, G., et al. (2022) · Metabolites · doi:10.3390/metabo12111019 · Cited by 26
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2023) · Nutrients · doi:10.3390/nu15245080 · Cited by 26
“Some emerging special dietary patterns such as energy-restricted/intermittent fasting diets [25] and ketogenic diets [26] have reported positive significance in assisting intervention under specialized supervision.”
BackgroundPondel, N., Liśkiewicz, D., & Liśkiewicz, A. (2020) · Postępy Biochemii · doi:10.18388/pb.2020_342 · Cited by 33
Exploring the effect of different diet types on ageing and age-related diseases
Mensah, E. O., Danyo, E. K., & Asase, R. V. (2024) · Nutrition · doi:10.1016/j.nut.2024.112596 · Cited by 24
Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
Bajracharya, R., Youngson, N. A., & Ballard, J. W. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081850 · Cited by 23
“We have focussed on these new proposals, and not on previously described diets for management of PD such as the ketogenic diet and caloric restriction as these has been well covered elsewhere [144,145].”
Wang, X., Yang, Y., Xiao, A., Zhang, N., Miao, M., Wang, Z., Han, J., & Wen, M. (2022) · Food & Function · doi:10.1039/d1fo04087a · Cited by 24
MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet
Gzieło, K., Janeczko, K. J., Węglarz, W. P., Jasiński, K., Kłodowski, K., & Setkowicz, Z. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02111-9 · Cited by 22
“For this uptake, KD provides more energy than a normal diet because metabolized fat delivers more energy than glucose (Włodarek 2019).”
BackgroundSridharan, B., & Lee, M. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666211004104703 · Cited by 26
Ortí, J. E. D. L. R., Fernández, D., Platero, F., & García-Pardo, M. P. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.744398 · Cited by 25
“Besides, this ketogenesis is more effective when the fats, instead of being long chain fatty acids (LCFA) (which represents the classical version of the diet) (54) are medium chain triglycerides (MCT) made up of MCFA, as it increases the concentration of ketone bodies in blood even if carbohydrates are present in diet…”
BackgroundHamamah, S., Hajnal, A. S., & Covașă, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147503 · Cited by 25
“to the gastrointestinal involvement with the onset of PD, numerous studies have examined the role of nutrition and associated changes in gut microbiota composition on dopamine bioavailability [8,9].”
BackgroundThe effect of the ketogenic diet on Acne: Could it be a therapeutic tool?
Barrea, L., Cacciapuoti, S., Megna, M., Verde, L., Marasca, C., Vono, R., Camajani, E., Colao, A., Savastano, S., Fabbrocini, G., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2176813 · Cited by 24
“The ICKD is mainly used in neurodegenerative diseases such as Parkinson’s (Wlodarek 2019) or Alzheimer’s (Rusek et al. 2019), or for the treat-ment of migraine (Barbanti et al. 2017), headache (Di Lorenzo et al. 2021), drug-resistant epilepsy (Wells et al. 2020), or in other diseases in which…”
MethodPerspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans
Hansen, B., Roomp, K., Ebid, H. H., & Schneider, J. G. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100197 · Cited by 24
Mallet, D., Goutaudier, R., Barbier, E., Carnicella, S., Colca, J. R., Fauvelle, F., & Boulet, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02962-9 · Cited by 22
Enhancing cognitive function in older adults: dietary approaches and implications
Polis, B., & Samson, A. O. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1286725 · Cited by 22
“One such approach is the ketogenic diet, which has been studied for its potential benefits in various health conditions, including AD and other neurodegenerative diseases (98).”
BackgroundEbertowska, A., Ludkiewicz, B., Klejbor, I., Melka, N., & Moryś, J. (2020) · Folia Morphologica · doi:10.5603/fm.a2020.0020 · Cited by 21
Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts
Hanyuda, A., ROSNER, B. A., Wiggs, J. L., Willett, W. C., Tsubota, K., Pasquale, L. R., & Kang, J. H. (2020) · Eye · doi:10.1038/s41433-020-0820-5 · Cited by 21
“1% carbohydrate and 90% fat) [16] which in humans have been linked to poor adherence [48, 49].”
BackgroundXu, Y., Zheng, F., Zhong, Q., & Zhu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230002 · Cited by 22
“Muscle pain, hypoglycemia, hypocalcemia, hypercalciuria, and hypertriglyceridemia belong to the early side effects of KD treatment [21, 227].”
Benitez, L. O., Castagnini, J. M., Añón, M. C., & Salgado, P. R. (2019) · LWT · doi:10.1016/j.lwt.2019.108809 · Cited by 20
Ketogenic diet: A nutritional remedy for some metabolic disorders
Kayode, O. T., Rotimi, D. E., Afolayan, O. A., & Kayode, A. A. A. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.08.021 · Cited by 20
Ye, Y., Chai, S.-F., Li, X.-R., Wu, M., Cai, H.-Y., & Wang, Z.-J. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01288-2 · Cited by 19
“Few studies have assessed the effects of KD on AD, and data on the long-term use of KD in AD patients or its effects on disease symptoms are not available (Wlodarek 2019).”
Nathan, J. K., Kale, D. K., Naik, V. D., Thakker, F., & Bailur, S. (2019) · Cureus · doi:10.7759/cureus.5485 · Cited by 19
“Ketones increase autophagy and reduce levels of hyperphophorylated NFTs deposition in the hippocampus, amygdala, and cortex in Alzheimer’s patients [13].”
BackgroundYin, L., Liu, Q., Jia, Z., & Guo, B. (2025) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2025.05.004 · Cited by 18
Gudan, A., Skonieczna‐Żydecka, K., Palma, J., Drozd, A., & Stachowska, E. (2022) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2022.0196 · Cited by 18
mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
Norwitz, N. G., & Querfurth, H. W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00775 · Cited by 18
“…ketogenic diets as prevention or treatment strategies for neurodegenerative conditions (Roberts et al., 2017; Zhang et al., 2017; Shin et al., 2018; Sohn, 2018; Taylor et al., 2018, 2019; Broom et al., 2019; Norwitz et al., 2019a; Wlodarek, 2019; Mujica-Parodi et al., 2020; Soto-Mota et al., 2020).”
BackgroundEffects of a low-carbohydrate ketogenic diet on health parameters in resistance-trained women
Vargas-Molina, S., Carbone, L., Romance, R., Petro, J. L., Schoenfeld, B. J., Kreider, R. B., Bonilla, D. A., & Benítez‐Porres, J. (2021) · European Journal of Applied Physiology · doi:10.1007/s00421-021-04707-3 · Cited by 19
“Emerging evidence has suggested KDs may have potential clinical uses in neurodegenerative diseases (Włodarek 2019; Veech 2004), as a therapeutic aid in some types of cancer (Allen et al.”
BackgroundJohn, A. A., Ali, K., Marsh, H. D., & Reddy, P. H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101406 · Cited by 18
Gangitano, E., Tozzi, R., Mariani, S., Lenzi, A., Gnessi, L., & Lubrano, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.771047 · Cited by 18
“The prescription of KD is currently under consideration in other pathologies than obesity, as headache (10), polycystic ovary syndrome (11), cancer (12), and neurodegenerative diseases (13, 14).”
BackgroundBolesławska, I., Kowalówka, M., Bolesławska-Król, N., & Przysławski, J. (2023) · Viruses · doi:10.3390/v15061262 · Cited by 18
Ketogenic diet: a potential adjunctive treatment for substance use disorders
Kong, D., Sun, J., Yang, J.-Q., Li, Y.-S., Bi, K., Zhang, Z., Wang, K., Luo, H.-Y., Zhu, M. J., & Xu, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1191903 · Cited by 18
“Also, some researchers have shown concerns during the application of KD in neurological diseases, such as decreased appetite, increased risk of malnutrition, and the occurrence of some adverse effects (231).”
BackgroundKetogenic regimens for acute neurotraumatic events
Yarar‐Fisher, C., Li, J., Womack, E. D., Alharbi, A., Seira, O., Kolehmainen, K., Plunet, W. T., Alaeiilkhchi, N., & Tetzlaff, W. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.12.009 · Cited by 20
Zhou, J., Tang, M., Li, W., Fang, R., Tang, C., & Wang, Q. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250049 · Cited by 16
Plasma oxylipin profiles reflect Parkinson's disease stage
Chistyakov, D. V., Azbukina, N. V., Lopachev, A. V., Goriainov, S. V., Astakhova, A. A., Ptitsyna, E. V., Сергеевна, К. А., Poleschuk, V. V., Kazanskaya, R. B., Федорова, Т. Н., et al. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106788 · Cited by 18
Yan, J., Han, V. X., Jones, H. F., Couttas, T. A., Jieu, B., Leweke, F. M., Lee, J., Loi, C., Webster, R., Kothur, K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105664 · Cited by 17
“…a response to the carbohydrate deprivation in KD. KD is a novel dieto-therapeutic approach with potential to reduce in fl ammation and modulate cell function and signalling in a variety of health disorders such as neurological disorders, 46 – 48 epilepsy, 49 cardiovascular diseases, 50 and cancer.”
Ketogenic Diet and Gut Microbiota: Exploring New Perspectives on Cognition and Mood
Jiang, Y., Chen, Y., Chen, Y., Gong, X., Chen, Z., & Zhang, X. (2025) · Foods · doi:10.3390/foods14071215 · Cited by 19
“…can mimic or amplify the benefits of the KD [70–72] (Figure 3). interest in developing food-based interventions, such as MCT-enriched products and probiotics, that can mimic or amplify the bene fi ts of the KD [70–72] (Figure 3). enzyme in serotonin synthesis, thereby enhancing 5-HT production [67].”
A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice
Ryals, R. C., Huang, S. J., Wafai, D., Bernert, C., Steele, W., Six, M., Bonthala, S., Titus, H. E., Yang, P. G., Gillingham, M. B., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.11.18 · Cited by 16
“8,12 Because the retina is part of the central nervous system, we sought to investigate the potential of a ketogenic diet to induce neuroprotection in photoreceptor degenerations.”
Effect of the ketogenic diet in excitable tissues
Murano, C., Binda, A., Palestini, P., Baruscotti, M., DiFrancesco, J. C., & Rivolta, I. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2020 · Cited by 16
Metabolic Strategies in Healthcare: A New Era
Phillips, M. C. L. (2022) · Aging and Disease · doi:10.14336/ad.2021.1018 · Cited by 21
“KDs generally slow neurodegeneration and improve functional outcomes in animal models of AD and PD [138].”
BackgroundHope, K. W. (2020) · British Journal of Nursing · doi:10.12968/bjon.2020.29.8.460 · Cited by 19
Mechanical, sensory, and consumer evaluation of ketogenic, gluten‐free breads
Gillespie, R., & Ahlborn, G. J. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2308 · Cited by 18
“A sampling of papers on glutenrelated conditions and diseases are available for review (Aziz et al., 2016; Aziz & Sanders, 2012; Lerner et al., 2019; Mansueto et al., 2014; Rotondi Aufiero et al., 2018; Singh et al., 2018; Tanveer & Ahmed, 2019; Włodarek, 2019).”
BackgroundSerum lipids and the pathogenesis of Parkinson's disease: A systematic review and meta‐analysis
Lu, Y., Jin, X., & Zhao, P. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13865 · Cited by 16
Hung, P., Lin, J., Chen, C., Hung, K.-Y., Hsieh, T.-Y., Hsu, M., Kuo, H.-C., & Lin, Y.-J. (2020) · Nutrients · doi:10.3390/nu13010021 · Cited by 18
Hu, J., Wang, Z., Lei, B., Li, J., & Wang, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010740 · Cited by 19
Mitochondria-Microbiota Interaction in Neurodegeneration
Krämer, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.776936 · Cited by 14
“Still, for elderly people who are degenerating and have already begun to lose weight, such dieting may no longer be advisable (Włodarek, 2019) (see also section “Mitochondria’s Oxygen Consumption Benefits the Microbiota”).”
BackgroundIntermittent Fasting and Brain Health: Efficacy and Potential Mechanisms of Action
Francis, N. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2002121 · Cited by 15
Salido‐Bueno, B., Gil-Hernández, E., Rueda‐Ruzafa, L., Gómez‐Chica, P., Román, P., & Cardona, D. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12693 · Cited by 13
Kravchenko, G., Stephenson, S. S., Gutowska, A., Klimek, K., Chrząstek, Z., Pigłowska, M., Kostka, T., & Sołtysik, B. K. (2024) · Nutrients · doi:10.3390/nu16213756 · Cited by 14
Nagpal, D., Nema, S., Nagpal, S., Pandey, M. M., Kaushik, D. K., & Kathuria, H. (2025) · Antioxidants · doi:10.3390/antiox14091078 · Cited by 19
“People with neurodegenerative conditions are at greater risk of developing malnutrition [171].”
Malnutrition delayed wound healing after tooth extraction by HMGB1-related prolonged inflammation
Zhang, Y., Ideguchi, H., Aoyagi, H., Yamashiro, K., Yamamoto, T., Nishibori, M., & Takashiba, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107772 · Cited by 14
Das, S., Sakr, H. F., Sirasanagandla, S. R., Bima, A. I. H., & Elsamanoudy, A. Z. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220511121629 · Cited by 15
The Role of a Ketogenic Diet in the Treatment of Dementia in Type 2 Diabetes Mellitus
Bai, L., Zhou, Y., Zhang, J., & Ma, J. (2023) · Nutrients · doi:10.3390/nu15081971 · Cited by 12
Two-month ketogenic diet alters systemic and brain metabolism in middle-aged female mice
Roslund, K. J., Ramsey, J. J., Rutkowsky, J. M., Zhou, Z., & Slupsky, C. M. (2024) · GeroScience · doi:10.1007/s11357-024-01314-w · Cited by 12
“Much research has focused on the effects of a KD as a therapeutic for epilepsy [18], neurodegenerative disorders [19, 20], weight loss [21], metabolic disease [22], and cancers [23, 24].”
Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s Disease
Sobral, J., Empadinhas, N., Esteves, A. R., & Cardoso, S. M. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae208 · Cited by 13
To, J. Q., Shao, Z. Y., Gandawidjaja, M., Tabibi, T., Grysman, N., & Grossberg, G. T. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00407-2 · Cited by 12
Nutrition and Gut–Brain Pathways Impacting the Onset of Parkinson’s Disease
Terenzi, D., Muth, A.-K., & Park, S. Q. (2022) · Nutrients · doi:10.3390/nu14142781 · Cited by 12
Western and ketogenic diets in neurological disorders: can you tell the difference?
Habashy, K. J., Ahmad, F. A., Ibeh, S., Mantash, S., Kobeissy, F., Issa, H., Habis, R., Tfaily, A., Nabha, S. M., Harati, H., et al. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac008 · Cited by 12
Mechanisms of Ketogenic Diet Action
Williams, R. S. B., Boison, D., Masino, S. A., & Rho, J. M. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0079 · Cited by 14
Beyond epilepsy management: A narrative review of the health effects of ketogenic diets
Chamma, L., Chamma, N., Mattar, L., Slaybe, M. A., Haidar, S. A., & Rizk, R. (2025) · Nutrition · doi:10.1016/j.nut.2025.112804 · Cited by 11
The ketogenic diet: a co-therapy in the treatment of mood disorders and obesity - a case report
Pieklik, A., Pawlaczyk, M., Róg, J., & Karakuła‐Juchnowicz, H. (2021) · Current Problems of Psychiatry · doi:10.2478/cpp-2021-0002 · Cited by 11
Beliefs and Experiences of Individuals Following a Zero-Carb Diet
Protogerou, C., Leroy, F., & Hagger, M. S. (2021) · Behavioral Sciences · doi:10.3390/bs11120161 · Cited by 12
Gureev, A. P., Silachev, D. N., Sadovnikova, I. S., Krutskikh, E. P., Chernyshova, E. V., Volodina, D. E., Samoylova, N. A., Potanina, D. V., Burakova, I. Y., Dmitrievna, S. Y., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03325-8 · Cited by 12
Does hazelnut consumption affect brain health and function against neurodegenerative diseases?
Talebi, S., Khodagholi, F., Bahaeddin, Z., Dezfouli, M. A., Zeinaddini-Meymand, A., Kankam, S. B., Foolad, F., Alijaniha, F., & Piranghar, F. F. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2296164 · Cited by 11
“Recent studies indicated that high content of fat and low carbs intake, such as in ketogenic diets, may protect neurons in di ff erent harmful conditions [61].”
Beta-Hydroxybutyrate: A Supplemental Molecule for Various Diseases
Shahtaghi, N. R., Soni, B., Bakrey, H., Bigdelitabar, S., & Jain, S. K. (2024) · Current Drug Targets · doi:10.2174/0113894501312168240821082224 · Cited by 10
Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome
Shao, W., Liu, L., Gu, J., Yang, Y., Wu, Y., Zhang, Z., Xu, Q. Y., Wang, Y., Shen, Y. L., Gu, L., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03304-8 · Cited by 10
“Current studies have shown that KD can be used to rescue many different conditions, including obesity [150], type 2 diabetes [151], neurodegenerative disorders(e.g., Alzheimer ’ s disease, Parkinson ’ s disease) [152], and autism spectrum disorders [153].”
Włodarek, D. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000752 · Cited by 11
“The classical KD provides 85% of energy from fat, up to 8% from carbohydrates, and approximately 7% from protein [3].”
BackgroundInfluentialSelf-citationExploring the metabolomic profile of cerebellum after exposure to acute stress
Iliou, A., Vlaikou, A., Nußbaumer, M., Benaki, D. C., Mikros, E., Gikas, E. E., & Filiou, M. D. (2021) · Stress · doi:10.1080/10253890.2021.1973997 · Cited by 10
“Several studies have shown that ketogenic diet interventions could exert strong neuroprotective effects on social behavior and cognition (Wlodarek, 2019).”
BackgroundWhat Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?
Benarroch, E. E. (2022) · Neurology · doi:10.1212/wnl.0000000000200920 · Cited by 11
“However, there are multiple potential adverse effects of ketogenic diet, which may be particularly relevant in patients with neurodegenerative disorders.(133) Furthermore, proinflammatory microglia may be potentially protective in certain disease stages.”
BackgroundKetones in the Life Sciences – Biochemistry, Metabolism, and Medicinal Significances
Kuykendall, N. S., & Kuykendall, J. R. (2024) · Biochemistry · doi:10.5772/intechopen.114276 · Cited by 11
Nutritional aspects in Parkinson’s disease
Gątarek, P., & Kałużna‐Czaplińska, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1902261 · Cited by 10
“Neuroprotective effects caused by ketone bodies result from the increase in mitochondrial respiration via an increase in adenosine triphosphate production (ATP) (Barichella, Cereda, and Pezzoli 2009; Shaafi et al. 2016; Schirinzi et al. 2019; Włodarek 2019).”
BackgroundThe ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9
Halhouli, O., Zhang, Q., & Aldridge, G. M. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.018 · Cited by 10
Hong, M., Cheng, L., Liu, Y., Wu, Z., Zhang, P., & Zhang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.823902 · Cited by 9
“PD is a common neurodegenerative disorder along with midbrain substantia dopamine neuron necrosis in middle-aged and elderly people, huge reduced striatal dopamine, occurrence of α-Synuclein (α-Syn) aggregates in cells as well as formation of Lewy Body-predominant in neurons (Włodarek, 2019).”
BackgroundGut microbiota and Parkinson’s Disease: a new frontier in understanding neurological health
Kumari, N., Addepalli, V., More, A., Patil, A., & Suryawanshi, M. V. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01726-w · Cited by 9
“An imbalance between the state of antioxidants and oxidants causes this disease (Włodarek 2019).”
Feasibility of an MI-CBT ketogenic adherence program for older adults with mild cognitive impairment
Sheffler, J., Arjmandi, B. H., Quinn, J. M., Hajcak, G., Vied, C., Akhavan, N. S., & Naar, S. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-00970-z · Cited by 9
“Recent studies indicate that ketogenic nutrition targets multiple neurobiological mechanisms associated with the development of Alzheimer’s disease, such as defects in mitochondrial function, cerebrospinal fluid biomarkers, insulin signaling, and dysfunctional glucose and lipid metabolism [3, 6, 7].”
BackgroundKOTUSIEWICZ, W., SIEKIERKO, N., ŻOŁNIEREK, M., Lubczyńska, Z., POPRAVKO, Y., ŚWIĘTOCHOWSKI, J., Lewandowski, M. M., & Bienia, G. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.04.037 · Cited by 8
Iyer, S. H., Yeh, M. Y., Netzel, L., Lindsey, M. G., Wallace, M., Simeone, K. A., & Simeone, T. A. (2024) · Nutrients · doi:10.3390/nu16040553 · Cited by 8
“Preclinically, the KD has neuroprotective effects in both AD and epilepsy through inducing ketosis, reducing blood sugar concentrations and neuroinflammatory cytokines, increasing fatty acid oxidation and mitochondrial respiration, and reducing oxidative stress and ROS generation [6,8,30,110–114].”
BackgroundTake the bull by the horns and tackle the potential downsides of the ketogenic diet
Meng, Y., Sun, J., & Zhang, G. (2024) · Nutrition · doi:10.1016/j.nut.2024.112480 · Cited by 8
Fan, L., Zhu, X., Borenstein, A. R., Huang, X., Shrubsole, M. J., Dugan, L. L., & Dai, Q. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.37 · Cited by 9
“The classic ketogenic diet is too strict to maintain long-term (8) and can lead to side effects (9–11).”
Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants
Santos, A. L., & Sinha, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_15 · Cited by 8
Popescu, I. R., Lenain, M., Rovini, E., & Ruthsatz, M. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251330170 · Cited by 8
Rojas, R., Griñán‐Ferré, C., Castellanos, A., Griego, E., Martínez, M., Navarro‐López, J. D., Jiménez‐Díaz, L., Rodríguez-Álvarez, J., Soto, D., Castillo, P. E., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102207 · Cited by 7
“Considering that a ketogenic diet and intermittent fasting often face challenges in lasting adherence [67], dietary BHB supplementation may yield more satisfactory long-term outcomes to prevent weight gain and cognitive impairments linked to metabolic diseases.”
Cheng, S., Cheng, C., Zhou, J., Ji, Y. S., Liu, Y., Jiang, W., Liu, C., & Wang, H. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf258 · Cited by 11
Ferguson, C. C., Jung, S. E., Lawrence, J. C., Douglas, J. W., Halli-Tierney, A. D., Bui, C., & Ellis, A. C. (2022) · Journal of Applied Gerontology · doi:10.1177/07334648221118358 · Cited by 7
“…& Thiele, 2016; Olanow & Koller, 1998) Research is emerging on dietary patterns that may be optimal for people with PD, such as the ketogenic, Mediterranean, and Mediterranean DASH Intervention for Neurodegenerative Delay (MIND) diets (Agarwal et al., 2018; Cassani et al., 2017; Wlordarek, 2019).”
BackgroundToxicity Investigations of (R)-3-Hydroxybutyrate Glycerides In Vitro and in Male and Female Rats
Dolan, L. C., Karikachery, A. R., Thipe, V. C., Arceneaux, B. G., Katti, K. K., Katti, K. V., & Chesne, A. M. (2022) · Nutrients · doi:10.3390/nu14204426 · Cited by 8
Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230502123255 · Cited by 10
Diet as a Modulator of Gut Microbiota May Reduce Alzheimer’s Disease Risk
Ochocińska, A., Podstawka, I., Kępka, A., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17193053 · Cited by 6
Diet for the prevention and treatment of Parkinson’s disease
Chen, W., Fan, T., & Xu, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1587246 · Cited by 6
“In addition, long-term adherence to a KD can lead to loss of appetite, gastrointestinal discomfort, and other side effects (125), however, the elderly often suffer from possible concomitant diseases such as diabetes and malnutrition, which affects compliance and limits the application of KD (126).”
Dynamic changes in nutritional status and sleep disturbance in Parkinson's disease
Xie, B., Bao, J., Zhang, L., Wu, Z., & Zhao, H. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112855 · Cited by 6
“These disturbances manifest as difficulties in falling asleep, frequent nocturnal awakenings, sleep fragmentation, REM sleep behavior disorder, and restless legs syndrome (W ł odarek, 2019).”
Linking Nutrients to Multiple Sclerosis Pathogenesis: Biological Evidence and Clinical Implications
Rosso, R., Maglione, A., Bronzini, M., Virgilio, E., Clerico, M., & Rolla, S. (2025) · Nutrients · doi:10.3390/nu17213414 · Cited by 6
“These metabolic adaptations contribute to reduced inflammation and neuroprotection [175].”
Coconut Oil and its Constituents as a Treatment for Alzheimer's Dementia
Guttmann, R. P., Sims, P., Churchill, C. L., Waters, C., Berry, B., & Wells, J. (2020) · Journal of Student Research · doi:10.47611/jsr.v9i1.1046 · Cited by 7
“A mechanism investigated in CO supplementation is the shift from glucose consumption to the usage of KBs, which serves as an alternate source of energy for brain tissues [12, 13].”
BackgroundPersonalized Healthcare for Dementia
Lee, S., Cho, E., & Kwak, H. (2021) · Healthcare · doi:10.3390/healthcare9020128 · Cited by 7
Şimşek, H., & Uçar, A. (2022) · Advances in Gerontology · doi:10.1134/s2079057022020175 · Cited by 6
Prevention of Neurologic Disease with Fasting
Macri, E., & Azhar, Y. (2022) · Seminars in Neurology · doi:10.1055/a-1957-8449 · Cited by 6
Golpour-Hamedani, S., Askari, G., Khorvash, F., Kesharwani, P., Bagherniya, M., & Sahebkar, A. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149348 · Cited by 5
Lane, J., & Fontaine, K. R. (2021) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2102015 · Cited by 5
Üstündağ, H., Doğanay, S., Öztürk, B., Köse, F., Kurt, N., Celep, N. A., Huyut, M. T., & Özgeriş, F. B. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/5562120 · Cited by 7
Metadata
- Authors
- Włodarek, D.
- Affiliations
- Warsaw University of Life Sciences (PL)
- Corresponding author
- Włodarek, Dariusz
- ORCID
- Włodarek, Dariusz
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 169
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356942
- OpenAlex
- W2910859275
- Semantic Scholar
- 7d537ea1be5b6de5ff1d316704c5f868eee0291a
- Cited by
- 301
- References
- 53
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 39 · 2023: 46 · 2022: 55 · 2021: 52 · 2020: 40 · 2019: 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- ketogenic diet, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, ketosis, neuroprotection, drug-resistant epilepsy, malnutrition, appetite suppression, gastrointestinal adverse effects, elderly patients, hypophagia
- MeSH terms
- Alzheimer Disease, Appetite, Brain, Feeding Behavior, Humans, Ketosis, Nutritional Status, Parkinson Disease, Malnutrition, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.